Mission Bio Launches First Automated Custom Panel Designer for Mouse Genomes and CRISPR Editing to Accelerate Breakthroughs in Cancer Research

Mission Bio Launches First Automated Custom Panel Designer for Mouse Genomes and CRISPR Editing to Accelerate Breakthroughs in Cancer Research: Researchers at Stanford University, MD Anderson Cancer Center (MDACC), the University of California at San Francisco (UCSF) and the University of Pennsylvania (Penn) have all leveraged the Tapestri Platform to support their research for characterizing clonal dynamics in AML, identifying MRD, and monitoring treatment response and therapy resistance. The company’s award-winning technology is also leveraged by LabCorp and Onconova Therapeutics to enable more efficient clinical trials.